Filing Details
- Accession Number:
- 0001140361-14-035027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-08 18:22:00
- Reporting Period:
- 2014-09-05
- Filing Date:
- 2014-09-08
- Accepted Time:
- 2014-09-08 18:22:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1379006 | Nanoviricides Inc. | NNVC | Services-Commercial Physical & Biological Research (8731) | 760674577 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1513285 | Anil Diwan | 135 Wood Street West Haven CT 06516 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2014-08-25 | 28,571 | $3.50 | 2,044,918 | No | 4 | P | Indirect | Held by AllExcel, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held by AllExcel, Inc. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants | Disposition | 2014-08-25 | 28,571 | $0.00 | 28,571 | $3.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-08-22 | 2014-08-15 | No | 4 | X | Indirect |
Footnotes
- Includes 285,714 shares issuable upon exercise of options. Does not include 1,750,000 shares of common stock underlying 500,000 shares of the Company's Series A Convertible Preferred Stock ("Series A") convertible into three and one half shares of Common Stock solely upon a change in control of the Company or upon achieving certain trading prices or 9,531,429 shares of common stock and 2,000,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.